Intelligent Control acts as the system’s “brain”, adeptly processing 3D spatial data for precise, automated pulse delivery. This innovation, alongside the new autodynamic pulsing feature, adapts to the operator’s speed, dramatically reducing full-body treatment times while ensuring uniform results across treatments.

Emphasizing patient safety, the technology simplifies the training process for new or less experienced technicians without compromising patient outcomes. BBL HEROic promises transformative results, delivering healthy, clear, and revitalized skin after just a single session. Kathy Ziegler, Director of Product Management at Sciton, shared her enthusiasm: “BBL HEROic is set to redefine the pulsed-light industry. By integrating Intelligent Control with our BBL® HERO™ technology, we’ve responded to the demand for a light-based treatment that is not only faster and more efficient but also accessible to staff across all skill levels, promising remarkable results.”

Leveraging advanced machine intelligence, BBL HEROic tracks the treatment handpiece in six degrees of freedom for real-time, multi-dimensional positioning, ensuring precise pulse placement on both flat and contoured body areas.

Available on both the JOULE®X and mJOULE™ platforms, BBL HEROic seamlessly integrates into aesthetic practices of any size, boosting patient demand and increasing revenue. Sciton will host six regional seminars across the country, offering providers an in-depth look at BBL HEROic, complete with hands-on demonstrations.

For more information on BBL HEROic or to register for a seminar, visit www.bblheroic.com.

The post Sciton Inc. Launches Revolutionary BBL HEROic: A New Era in Pulsed Light Technology appeared first on Sciton.

As the aesthetic world continues to thrive and evolve, practitioners are increasingly looking for reliable and customizable platforms to successfully treat a wide range of patient skin concerns. Sciton’s mJOULE platform, originally launched in 2019, was specifically designed to meet that need by offering a powerhouse system that hosts multiple consumer-recognized treatments, all within a compact and mobile footprint. Now, the option to add the 1064 nm wavelength to the mJOULE system gives providers the ability to further expand their treatment offerings with vascular treatment solutions that are proven to give life-changing results to an even broader range of patient concerns.

Rick Menefee, Sciton’s Head of R&D states, “At Sciton, we always keep our providers top of mind and constantly ideate on how to make our treatments the most efficient and effective. Adding the 1064 Nd:YAG wavelength to our small footprint platform was an important step in making mJoule the most versatile aesthetic solution for providers – no matter their specialty.”

Providers who invest in the new mJOULE system with 1064 will receive the latest treatment handpieces which feature fiber delivery for higher power, more spot sizes for increased speed, and more indication applications, as well as updates to software and our proven Subsurface Vein Illumination technology.

“Sciton continues to redefine the future of lasers and light by bringing to market the most advanced and quality-engineered products. The combination of 1064 in the ClearV and ClearSilk delivery systems with the narrowband 532+™ BBL ® filter replaces the need for all other vascular lasers in your practice. There isn’t a single vascular indication in all of laser medicine that cannot be addressed by this incredible platform,” says Sherrif Ibrahim, MD, PhD, founder of Rochester Dermatologic Surgery.

Interested providers are encouraged to visit /1064 for more information.

The post Sciton Announces The Expansion Of Their mJOULE System With 1064 Nd:YAG Wavelength appeared first on Sciton.

PALO ALTO, Calif., Sept. 1, 2021 — Sciton Inc., a leading manufacturer of medical and aesthetic lasers and light source technologies, today announces the launch of its highly anticipated BBLINK™ Goggles.

Introduced at Sciton’s 2021 Global Team Meeting in Denver, these smart glasses physically blink for the user to block out strain-inducing light flashes, leading to improved treatment visibility and an overall more pleasant experience for the practitioner. The exciting meeting also marked the first time in 18 months that the Sciton US teams came together in person.

First of its kind, BBLINK™ Goggles feature proprietary technology which connects directly with Sciton BBL® systems and receives shutter close commands from the system’s computer slightly before the light flash occurs. This allows users to keep up with the high-speed pulsing of BBL® HERO™, while still allowing them to see everything but the flash. No other shutter goggles on the market today match the flash speed or syncing capability. BBLINK™ works with all modalities of BBL including HERO, Forever Young™, Forever Bare™, and SkinTyte™ to block every flash, every time.

The innovative design blinks so fast you almost wonder if the BBL is pulsing at all. “The BBLINK goggles are a huge improvement over existing safety glasses,” shares Jason Pozner, MD. “I don’t want to use BBL without them.”

Let BBLINK™ Goggles do the BBLink-ing for you:

• Proprietary shutter design automatically matches the speed of any BBL application
• Headaches and eye strain from basic IPL protection are a thing of the past
• Experience better visibility for precise placement of the BBL sapphire for perfect results every time
• Artfully designed with integrated IPL protective goggles, BBLINK offers True Block
• Quick and simple pairing with the JOULE®, mJOULE™ System
• Multiple goggles can be synced to the same system and used during the same treatment
• Can last an average full day of treatments

“Sciton has a 24-year history of raising the bar in aesthetic laser and light technology,” shared Sciton CEO, Aaron Burton. “This innovation and dedication to our partners doesn’t stop at our laser and light technologies. We constantly listen to our user feedback, and the BBLINK Goggles directly results from that feedback. We never stop working to improve the user experience.”

Sciton’s BBLINK Goggles can be purchased at www.sciton.com/store.

ABOUT SCITON
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.

The post Sciton Introduces Revolutionary BBLINK™ Goggles That Raise The Bar For Eye Protection appeared first on Sciton.

PALO ALTO, Calif., March 3, 2020 — Sciton Inc., a leading manufacturer of medical and aesthetic lasers and light source technologies concludes 2019 at an all-time high, promoting key executives, holding two sold-out user summits, and launching multiple new technologies while enjoying successive years of growth.

2019 was a record revenue year for Sciton, delivering the eighth consecutive year of growth and two of the best historic quarters in the history of the enterprise. According to Robb Brindley, Vice President of Sales, North America, “The defining factor for our growth and success is quite simply our people. It’s an absolute honor to serve alongside the most loyal and durable sales professionals in the industry today. Everyone knows we play the game differently than our big-box competitors and this starts and ends with a firm commitment to honoring loyalty and celebrating tenured performance. We retain our top talent and cherish the best-in-class service that they afford our customers. Our commitment to reliable quality shows in our approval ratings and we are excited to make 2020 our best year ever with the best people ever.”

Sciton Invests In Leaders

2020 is off to a monumental start with the appointment of a new CEO to Sciton. This week Jim Hobart announced the promotion of Aaron Burton to Chief Executive Officer.

Aaron has spent the last eight years at Sciton growing the Aesthetic Sales Team, Women’s Health Group, International Sales Team, and more recently operations in our World Headquarters in Palo Alto, CA. “He has devoted his career at Sciton to pushing boundaries and motivating teams to reach new records. He has made it widely known that his vision for the future is about maintaining the Sciton culture while forging forward with a growth mindset. Paramount to that success is taking care of our people who in turn wow our customers with amazing service. That’s an admirable quality from any leader and our global team is extremely excited to see what the future holds, says Jim Hobart, Founder and Chairman.”

In addition, 2019 was another year in which the company rewarded its high performers. In April, Robb Brindley was added to the Board of Directors as the current Vice President of Sales, North America, bringing with him nearly two decades of Sciton experience. During the Fall User Summit, another milestone promotion was announced with Lacee J. Naik being promoted to the position of Vice President of Marketing & Public Relations and granted the honor of advisor to the Board of Directors.

New Technologies Unveiled

The company’s legacy focuses on designing and engineering systems with revolutionary advancements that minimize obsolescence through an expandable multi-device platform. The JOULE X™ platform was launched at ASLMS 2019 leading the way as the most customizable laser and light performance system available today.

As an option for the JOULE X™ platform, Sciton unveiled novel technology with the new ClearV™ application for the treatment of unsightly blood vessels, broken capillaries, spider veins and vascular lesions. With one of a kind Subsurface Vein Illumination™ technology (SVI), it is now possible to visualize and treat veins that cannot be seen by the naked eye, empowering practitioners to deliver more comprehensive treatment outcomes.

The Clear Suite family of products, including ClearV™ (NEW), ClearSilk™(NEW), and ClearHair™, combined with BroadBand Light (BBL™), enable physicians to treat veins, skin, and hair from a single platform.

The company brought further innovation to the market with Sciton iQ™, a cloud-based data intelligence software program that provides its customers with real-time system and treatment data analytics to drive their business. Sciton iQ features data and dashboard audit reports on specific procedures giving practices an insightful business tool for intuitive planning and resource utilization.

Sciton’s commitment to making premier solutions begins in Silicon Valley where all of its products are developed and manufactured. From the moment Sciton opened its doors the organization has done everything necessary to create meaningful solutions that stand the test of time. In the process, Sciton has achieved the highest customer satisfaction in the industry as its technologies delight and power today’s practitioners to achieve new heights in clinical excellence and patient satisfaction.

Sciton’s 2019 User Summits Broke New Records

The company held two sold-out User Summits in Chicago and Dallas. Hosting over 800 people combined, guests learned from presentations from 30 plus industry leaders including:

Dr. Antonio Campo
Dr. Jason Emer
Dr. Jason Pozner
Dr. Jill Waibel
Dr. Julius Few
Dr. Patrick Bitter, Jr.
Mr. Tom Seery
Dr. David Sieber
Dr. Jay Burns

Sciton generates customer loyalty by providing award-winning technologies. Its commitment to delivering devices that last the lifetime of a practice is well known; 95% of the systems made are still in active clinical use. Patients benefit from the results-oriented treatments Sciton delivers worldwide with direct operations in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. “Sciton is dedicated to worldwide support and growth. We strive to be the innovative company you lean on.” says David Percival, Vice President & General Manager of International.

ABOUT SCITON
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.

The post The Aesthetic Company To Watch In 2020 Is Sciton, Inc. appeared first on Sciton.

Link to abstract: #

This study further proves that the HALO™ Hybrid Fractional Laser offers a safe and effective treatment for a multitude of skin conditions on the face and neck while giving patients the results they desire with limited downtime.” Jill Waibel, MD Miami Dermatology and Laser Institute

 “We are proud to offer our customers, patients,  and business partners substantial clinical evidence that the HALO Hybrid Fractional Laser delivers high patient satisfaction, results they demand, and with the minimal downtime they expect.” Lacee J. Naik, Director of Global Marketing

About HALO Hybrid Fractional Laser
HALO, the world’s first Hybrid Fractional Laser, applies tunable non-ablative (1470nm) and ablative (2940nm) wavelengths to the same microscopic treatment zone to maximize results and reduce downtime. Sciton’s new technology produces targeted, reproducible, effective results that improve the appearance of numerous skin conditions. Intelligent energy delivery, combined with Dynamic Thermal Optimization, ensures precise, even, safe treatments. HALO owners love achieving maximum return on their investment while exceeding their patients’ expectations. Easy to use and virtually painless, HALO sets the standard for the future of laser resurfacing by providing a safe and powerful long-term hybrid solution. As part of the multifaceted, expandable JOULE platform, HALO provides the practitioner with a dynamic and essential component of their aesthetic toolbox.

ABOUT SCITON
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.

The post Sciton Announces New Multi-Center Clinical Study on HALO appeared first on Sciton.

The post Sciton Announces Collaboration with Michelson Diagnostics Ltd. To Develop Oct Image-Guided Laser Applications appeared first on Sciton.

With this new program, Sciton offers four specialized pillars: clinical training, marketing tools, business development, and Sciton-sanctioned tools and courses. Many of the vendors also offer preferred pricing which customers can only get through Success Builder. Upon initial purchase of their JOULE™ laser system customers have the ability to add Success Builder points to their account which they can later use to buy offerings through the program.

“Physicians can use Success Builder points to come to my clinical preceptorships and learn advanced hands-on resurfacing techniques. But they can also use them for improving their search engine marketing, patient materials, and overall business development. Participating in Success Builder is going to be key to developing a successful practice,” said long-time Sciton customer, Dr. Jason Pozner, owner and plastic surgeon at Sanctuary Medical Center in Boca Raton, Florida. “It’s a testament to their commitment to us as physicians.”

With the delivery of their JOULE™ system, Success Builder customers receive a booklet filled with dozens of offerings and can also access the various services via the website: www.sciton.com/successbuilder. Through the enhanced program, customers have the ability to take additional clinical training courses, redesign their marketing materials and website, and experience preferred pricing with industry partners, among many other offerings.

ABOUT SCITON
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.

The post Sciton Announces Success Builder, A New Program Focused on Growing Practice Revenue and Patient Traffic appeared first on Sciton.

HALO delivers both ablative and non-ablative wavelengths to the same microscopic treatment zone: 1470 nm for coagulation and 2940 nm for ablation. The 1470 nm wavelength is used for delivering between 100 and 700 microns of coagulation to the epidermis and dermis, where solar damage exists. The 2940 nm wavelength is used to deliver from 0 to 100 microns of ablation to the epidermis of the skin. This gives HALO the unique ability to provide separate treatments for the epidermis, which heals quickly, and dermis which remodels more slowly over time. The operator may choose one of three coverage-based treatment levels, and HALO calculates the exact amount of energy necessary to complete a safe and effective treatment. Intelligent energy delivery, combined with Dynamic Thermal Optimization, ensures precise and even treatments, each and every time. The benefits of a HALO treatment include both epidermal and deeper dermal pigmentation and tone and texture in the skin.

HALO is available on the JOULE™ platform, which offers multiple modules to treat a wide range of indications.

ABOUT SCITON
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.

The post HALO, The World’s First Hybrid Fractional Laser (HFL); Ablative Results with Non-Ablative Downtime appeared first on Sciton.

The post Stanford University Study Finds Evidence That Broadband Light Treatment Promotes Youthful Skin on A Molecular Level appeared first on Sciton.

Worldwide, it is reported that onychomycosis, affects up to 5 percent of the population. The condition can lead to embarrassing and unsightly nails and even pain. Current treatment options range from home remedies to over-the-counter topical creams to prescription-based oral medications that can be highly toxic to liver function. The FDA’s clearance of Sciton’s JOULE ClearSense will allow practitioners to treat the millions of people affected by onychomycosis.

“Finally, we have a safe treatment option that works for treating onychomycosis. ClearSense is a definite advancement for the podiatry and dermatologic fields, offering patients and practitioners a reliable method to treat unsightly nail fungus without toxic side effects,” said Thomas Bembynista, DPM, Podiatrist in Independence, Missouri.

Jill S. Waibel, MD, founder, and owner of the Miami Dermatology & Laser Institute in Miami, Florida, commented, “Onychomycosis can be very challenging to treat with the options we have traditionally had. Patients who have never before had any success with other fungal therapies are seeing significant improvements in their affected nails using ClearSense.”

With Sciton’s commitment to offering maximum flexibility on a single platform, physicians can also treat additional dermatologic indications, including but not limited to warts. “The FDA’s clearance of Sciton’s ClearSense for patients with onychomycosis represents a new chapter for those suffering from a fungal infection of their nails. Sciton continues our commitment to offering versatile, cutting-edge technology, which enable doctors to offer safe and very effective treatments,” stated Dan Negus, President of Sciton.

ABOUT SCITON
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.

The post Sciton’s JOULE ClearSense™ Receives FDA Clearance for Onychomycosis appeared first on Sciton.